Atacama Therapeutics

Biotechnology Research • Wellesley, Massachusetts, United States • 1-10 Employees

Company overview

Headquarters	65 William St, Wellesley Hills, Massachusetts 02481, US
Phone number	+17815918927
Website	atacamatherapeutics.com
NAICS	541714
SIC	873
Employees	1-10

Key Contact at Atacama Therapeutics

Jonathan Reis

Founder, Member Board Of Directors

About Atacama Therapeutics

Atacama was founded by a team of experienced life science professionals to advance a treatment for hyperhidrosis and establishing proof-of-concept for TC-5214 in this indication. Hyperhidrosis represents a disease with a significant unmet medical and quality of life need where only a few treatments have been approved by regulatory authorities. Atacama expects to rapidly advance its program from proof of concept to a dose ranging study and anticipates initiating registration trials within two years. The Atacama team seek to develop a portfolio of dermatology focused products for worldwide markets. The team has identified opportunities for novel therapies for psoriasis and scleroderma and expects it may be able to advance these therapies from pre-clinical to clinical development next year.

Atacama Therapeutics revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Atacama Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Atacama Therapeutics has never raised funding before.